SEI Investments’s Pliant Therapeutics PLRX Stock Holding History

SEI Investments’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Hold	297,291	–	–	﹤0.01%	2810
2026 Q1	$375K	Hold	297,291	–	–	﹤0.01%	2752
2025 Q4	$363K	Hold	297,291	–	–	﹤0.01%	2647
2025 Q3	$440K	Hold	297,291	–	–	﹤0.01%	2297
2025 Q2	$345K	Buy	297,291 +50,283	+20%	+$71K	﹤0.01%	2349
2025 Q1	$333K	Buy	+247,008	New	+$1.5M	﹤0.01%	2299
2023 Q2	–	Sell	-11,354	Closed	-$302K	–	2743
2023 Q1	$302K	Buy	+11,354	New	+$323K	﹤0.01%	2336
2022 Q4	–	Sell	-19,653	Closed	-$411K	–	2645
2022 Q3	$411K	Buy	+19,653	New	+$376K	﹤0.01%	2179

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

SEI Investments's PLRX Position: Q2 2026 in Review

SEI Investments held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 297,291 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #2810.

SEI Investments first reported a position in PLRX in Q3 2022 and has held it in 8 quarters since. The position peaked at $440K in Q3 2025. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

SEI Investments held 297,291 shares of Pliant Therapeutics worth $339K as of Q2 2026.
SEI Investments left its Pliant Therapeutics share count unchanged in Q2 2026.
Pliant Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2810 holding.
SEI Investments first reported a position in Pliant Therapeutics in Q3 2022 and has held it in 8 quarters since.
SEI Investments's Pliant Therapeutics position peaked at $440K in Q3 2025.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.